Results 5,261-5,280 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Yes.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is that a "yes"?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Does the NTPF delegation agree that the pricing model needs to be overhauled?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I mean from a basic layman's point of view. There is a problem when it is €950 a week versus €1,500 a week.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: We heard a different story earlier on, in fairness.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Yes.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: That is a matter of fact.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Does Mr. Horan like the system the way it is?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is the review finished but not published?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: What is the criteria?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Yes.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: The NTPF is one half of the equation.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: The NTPF is one half of the equation that deals with public moneys, which is what we are interested in. Earlier, some points were made and it would be remiss of us not to put them to the NTPF.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: How does one decide? Let us say Marc MacSharry is in a nursing home in Sligo so it is what I get versus what Deputy Connolly gets in her nursing home in Galway, Dublin or wherever.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Let us say somebody, as mentioned earlier, borrowed €20 million to build a place but they should not have borrowed and overextended themselves. Is that kind of stuff taken into account? Is it just the operational costs that are taken into account when Mr. Horan says the NTPF considers the cost incurred evidence?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Am I correct to say that, regardless of whether a developer owes €100 million or nothing, the bodies concerned approach that aspect in the same way?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I understand. I get the picture that it is just in terms of the cost incurred.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: How can the price charged pre-2009 be relevant?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I know.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I know. In terms of a scheme, pricing pre-2009 is ten years ago.